Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines ...

Researchers at UC San Francisco have now developed a way to reprogram these cancer-fighting cells directly inside the body. This new method could remove the need for external manufacturing, ...

Science rarely hands us plot twists this dramatic—where two of the most feared diseases of our time, cancer and Alzheimer’s, ...

Introduction to Graviola Graviola, known as Ramphal in Hindi, is predominantly found in tropical rainforests across Africa, ...

A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and ...

I read your column every day. In a recent column. you wrote: “Since age is the major risk factor in getting cancer, it is likely that some ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. In the United States and elsewhere, there’s been a major shift in ...

A first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people’s lung cells has been fast-tracked towards potential approval after promising clinical trial results. “Very ...

The National Cancer Institute is using federal funds to study whether cancer can be cured by ivermectin, a cheap, off-patent anti-parasitic and deworming drug that fringe medical groups falsely ...

One of President Donald Trump's first executive orders after his inauguration on Jan. 20, 2025, was for the U.S. to begin withdrawing from the WHO, blaming the organization's response to COVID and the ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best stocks under $3 to invest in. On January 9, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) announced that it expects to achieve its previously ...